First-in-human study of the novel fibroblast activation protein-targeted 4-1BB agonist RO7122290 in patients with advanced solid tumors

Supplementary source code

Authors

• Mariana Bustamante¹
• Eveline Nueesch¹
• Chiahuey Ooi¹
• Iakov I. Davydov¹

1. Roche Pharma Research and Early Development, Roche Innovation Center Basel; Basel, Switzerland

Would like to thank Nicolas Staedler who provided some of the codes used for analysis. We also would like to thank Alexandra-Cristina Nica who was involved in early stages of the analysis.